How Designer Microbes and the Organism Industry Will Reshape Our World
Many investors are captivated by the future of companies such as Tesla Motors and 3-D Systems -- and the potential creation of shareholder value on a scale that will be difficult to match. But are investors overlooking an even more promising industry with a brighter future?
Solazyme Follows Amyris Results With Impressive Developments of Its Own
Renewable oils manufacturer Solazyme is up today on positive developments from 2013 and early operations thus far in 2014. Here's what you need to know.
Why Anika Therapeutics, Amyris, and ExamWorks Are Today's 3 Best Stocks
The S&P 500 flatlines after more housing data, while Anika Therapeutics, Amyris, and ExamWorks explode to the upside.
Attention, Solazyme Investors: Don't Forget About Amyris
Synthetic biology pioneer Amyris discussed its full-year 2013 results after market close. Here's what investors need to know about 2013 and what you can expect from operations in 2014.
Amyris, Inc. Announces Plans to Increase Production Capacity by 400%
A newly amended Joint Venture Agreement sets Amyris on the path to $1 billion in product revenue by the end of the decade. The company generated an estimated $20 million in 2013.
How Solazyme, Inc. and Amyris, Inc. Bring Stability to a Risky World
Droughts and concerns of deforestation have ripped streaks of volatility through numerous raw materials that go into everyday products. Solazyme and Amyris are about to change that.
Big Companies Are Buying Into Biofuels
Big oil and chemical companies have financial resources and established infrastructure that is, at this point, unavailable to smaller biofuel companies. In the world of biofuels, maybe size does matter.
Solazyme, Inc. and Amyris, Inc. Will Make Sluggish Economic Growth a Distant Memory
The stock market holds its breath with every monthly economic report, but it seems to be ignoring a section of the economy that accounted for 7% of all GDP growth in 2011 and 2012. What is it, and how are Solazyme and Amyris driving it higher?
Can Shark Liver Oil Boost Biofuels?
Amyris continues to expand their market for renewable specialty chemicals as it ramps up production rates. Cosmetics and other niche markets will help to pay the bills while the biofuel market gains momentum.
Can Solazyme Inc Successfully Scale Biology?
Renewable oils company Solazyme recently announced the start-up of commercial operations at its Clinton, Iowa facility. The market sent shares 30% higher, but past obstacles in scaling biology at Amyris and Gevo may hint that the spike was a bit premature.